Pacific Biosciences of California PACB Accounts Receivable
Accounts Receivable at other companies
Other financials
Where this comes from
Reported directly by Pacific Biosciences of California in its filing.
Tagged under the XBRL concept us-gaap:AccountsReceivableNetCurrent.
The official record: Pacific Biosciences of California’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacific Biosciences of California's accounts receivable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pacific Biosciences of California's accounts receivable?
- Pacific Biosciences of California (PACB) reported accounts receivable of $29.35M in Q1 2026.
- How has Pacific Biosciences of California's accounts receivable changed year-over-year?
- Pacific Biosciences of California's accounts receivable decreased by 7.3% year-over-year, from $31.65M to $29.35M.
- What is the long-term trend for Pacific Biosciences of California's accounts receivable?
- Over 5 years (2020 to 2025), Pacific Biosciences of California's accounts receivable has grown at a 16.1% compound annual growth rate (CAGR), from $16.84M to $35.45M.
- What does accounts receivable mean?
- Amounts owed by customers for goods delivered or services performed, net of allowances for doubtful accounts. A key working capital component.